The multilayer flow modulator (MFM; Cardiatis, Isnes, Belgium) is a self-expandable mesh of braided cobalt alloy wires, used for treatment of aortic and peripheral aneurysms. To further improve our understanding of this novel technology, the endothelialization kinetics of the MFM was investigated and compared with those of two marketed single-layer stents. Five porcine animal models were used in which a total of 19 stents were implanted in the iliac and carotid arteries between one and five weeks before sacrifice. All 19 stents were successfully delivered. For all devices, nonsignificant signs of inflammation or thrombosis were noted, and there was no evidence of local intolerance. The MFM developed a thin layer of endothelial cells earlier and was associated with less neointimal development than the two single-layer stents. A differing phenomenon of integration was also revealed and hypothesized as endothelialization from adhesion of circulating endothelial progenitor cells, as well as adhesion from the arterial wall, and also by the differences in trauma exposed to the arterial wall.
Van BeusekomHMSerruysPW. Drug-eluting stent endothelium: Presence or dysfunction. JACC Cardiovasc Interv2010; 3: 76–77.
2.
De PradoAPPérez-MartínezCCuellas-RamónC. Time course of reendothelialization of stents in a normal coronary swine model: characterization and quantification. Vet Pathol2011; 48: 1109–1117.
3.
SimonsM. Angiogenesis. Where do we stand now?Circulation2005; 111: 1556–1566.
4.
CostaMASimonDI. Molecular basis of restenosis and drug-eluting stents. Circulation2005; 111: 2257–2273.
5.
DouglasGVan KampenEHaleAB. Endothelial cell repopulation after stenting determines in-stent neointima formation: effects of bare-metal vs. drug-eluting stents and genetic endothelial cell modification. Eur Heart J2013; 34: 3378–3388.
6.
KipshidzeNDangasGTsapenkoM. Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions. J Am Coll Cardiol2004; 44: 733–739.
7.
ZhuWTianYZhouLF. Development of a novel endothelial cell-seeded endovascular stent for intracranial aneurysm therapy. J Biomed Mater Res A2008; 85A: 715–721.
8.
FlugelmanMYVirmaniRLeonMB. Genetically engineered endothelial cells remain adherent and viable after stent deployment and exposure to flow in vitro. Circ Res1992; 70: 348–354.
9.
Zhu C. Endothelial progenitor cell (EPG)-seeded intravascular stents. In: Li R-K and Weisel RD (eds) Cardiac regeneration and repair. Volume 2: biomaterials and tissue engineering. Cambridge, UK: Woodhead publishing Limited, 2014, p. 116.
10.
WaterhouseAWiseSGYinY. In vivo biocompatibility of a plasma-activated, coronary stent coating. Biomaterials2012; 33: 7984–7992.
11.
WangGXDengXYTangCJ. The adhesive properties of endothelial cells on endovascular stent coated by substrates of poly-l-lysine and fibronectin. Artif Cells Blood Substit Immobil Biotechnol2006; 34: 11–25.
12.
AndersonTF. Techniques for preservation of three dimensional structure in preparing specimens for electron microscopy. Trans NY Acad Sci1951; 13: 30–30.
13.
DonathKBrunnerG. A method for the study of nondecalcified bone and teeth with attached soft tissues. J Oral Pathol Med1982; 11: 318–326.
14.
HenryMPolydorouAFridN. Treatment of renal artery aneurysm with the multilayer stent. J Endovasc Ther2008; 15: 231–236.
15.
MeyerCVerrelFWeyerG. Endovascular management of complex renal artery aneurysms using the multilayer stent. Cardiovasc Intervent Radiol2011; 34: 637–641.
16.
PolydorouAHenryMBellenisI. Endovascular treatment of arterial aneurysms with side branches—a simple method. Myth or reality?Hosp Chron2012; 5: 88–94.
17.
FerreroEFerriMViazzoA. Visceral artery aneurysms, an experience on 32 cases in a single center: treatment from surgery to multilayer stent. Ann Vasc Surg2011; 25: 923–935.
18.
SultanSHynesN. Disruptive endovascular technology with multilayer flow modulator stents as a therapeutic option in the management of thoracoabdominal aortic aneurysms. Early results from the global independent MFM Regsitry. Ital J Vasc Endovasc Surg2012; 19: 215–218.
19.
SultanSHynesN. One-year results of the multilayer flow modulator stent in the management of thoracoabdominal aortic aneurysms and type B dissections. J Endovasc Ther2013; 20: 366–377.
20.
VaislicCDFabianiJNChocronS. One-year outcomes following repair of thoracoabdominal aneurysms with the multilayer flow modulator: report from the STRATO trial. J Endovasc Ther2014; 21: 85–95.
21.
ChocronSVaislicCKailiD. Multilayer stents in the treatment of thoraco-abdominal residual type B dissection. Interact Cardiovasc Thorac Surg2011; 12: 1057–1059.
22.
LiYSHagaJHChienS. Molecular basis of the effects of shear stress on vascular endothelial cells. J Biomech2005; 38: 1949–1971.
23.
WentzelJJKramsRSchuurbiersJC. Relationship between neointimal thickness and shear stress after Wallstent implantation in human coronary arteries. Circulation2001; 103: 1740–1745.
24.
CarlierSGvan DammeLCBlommerdeCP. Augmentation of wall shear stress inhibits neointimal hyperplasia after stent implantation: inhibition through reduction of inflammation?Circulation2003; 107: 2741–2746.
25.
BompaisHChagraouiJCanronX. Human endothelial cells derived from circulating progenitors display specific functional properties compared with mature vessel wall endothelial cells. Blood2004; 103: 2577–2584.
26.
HadiHARCarrCSAl SuwaidiJ. Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome. Vasc Health Risk Manag2005; 1: 183–198.
27.
HackamDGRedelmeierDA. Translation of research evidence from animals to humans. JAMA2006; 296: 1731–1732.
28.
WilliamsSMHainesJLMooreJH. The use of animal models in the study of complex disease: all else is never equal or why do so many human studies fail to replicate animal findings?Bioessays2004; 26: 170–179.
